Nav: Home

Blue mushroom dye used to develop new fluorescent tool for cell biologists

December 17, 2019

A new fluorescent tool for detecting reactive oxygen species based on a chemical found in mushrooms has been developed by scientists at the University of Bath.

Reactive oxygen species (ROS), such as free radicals and peroxides, are produced in cells under oxidative stress. Whilst present in healthy cells in small amounts, excessive ROS in cells are damaging and can lead to cancer and neurodegenerative diseases such as Alzheimer's Disease.

The scientists at Bath, collaborating with researchers in South Korea, have developed a new probe that biologists studying these diseases can use to see changes in cells under the microscope, helping them to understand the fundamental biological processes involving ROS.

They've created a family of new molecules - dubbed AzuFluor™ - based on azulene, a bright blue chemical found in the mushroom Lactarius indigo. It fluoresces when it comes into contact with a ROS in a one-way reaction, detecting tiny amounts of these reactive oxygen species.

Whilst most fluorescent probes absorb a single photon, AzuFluor™ absorbs two photons, meaning that two lower energy photons can be used to produce the same level of fluorescence. Using shorter wavelengths of light in infrared range means that the light can penetrate tissues more deeply without harming the cells. This technology has been shown to work in rat tissue; the researchers hope that in the future it could be used as a probe in the human body.

Dr Simon Lewis, Senior Lecturer in the Centre for Sustainable & Circular Technologies (CSCT) at the University of Bath, said: "AzuFluor™ is a much smaller molecule and simpler to make than other two-photon fluorophores. Its small size makes it easy to diffuse and transport into cells.

"We aim to make a family of these fluorophores that can be used in a range of cell imaging applications."

Professor Tony James, also from the CSCT at Bath, said: "This research has wide-ranging potential applications in cell biology and the pharmaceutical industry and is a great example of a fantastic international collaboration between chemists at Bath and Professor Hwan Myung Kim and his group at Ajou University in South Korea."
-end-
The research is published online: Lloyd Murfin et al (2019) "Azulene-Derived Fluorescent Probe for Bioimaging: Detection of Reactive Oxygen and Nitrogen Species by Two-Photon Microscopy" J. Am. Chem. Soc. 2019, 141, 19389-19396. DOI: 10.1021/jacs.9b09813

The research paper is featured in the latest JACS Spotlight and is one of the most read articles of the month from the journal.

University of Bath

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.